Beijing, September 15 (Reuters) - Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said. China has four COVID-19 vaccines in the final stage of clinical trials. At least three of those have already been offered to essential ...
September 10 (BBC News) - Shipping a coronavirus vaccine around the world will be the "largest transport challenge ever" according to the airline industry. The equivalent of 8,000 Boeing 747s will be needed, the International Air Transport Association (IATA) has said. There is no Covid-19 vaccine yet, but IATA is already working with airlines, airports, global health bodies and drug ...
August 14 (AFP) - The World Health Organization said on Wednesday it was looking forward to reviewing clinical trials of a potential coronavirus vaccine developed in Russia. President Vladimir Putin declared Russia the first country to approve a vaccine on Tuesday even though final stage testing involving more than 2,000 people was only due to start on Wednesday. The WHO ...
Moscow, August 11 (Reuters) - Russia has named its first approved COVID-19 vaccine ‘Sputnik V’ for foreign markets, a reference to the world’s first satellite and what Moscow sees as its success at becoming the first country to approve a vaccine, a top official said on Tuesday. Kirill Dmitriev, head of the country’s RDIF sovereign wealth fund, said Russia had ...
Moscow, August 11 (Reuters) - President Vladimir Putin said on Tuesday that Russia had become the first country in the world to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing, a move hailed by Moscow as evidence of its scientific prowess. The vaccine still has to complete final trials, raising concerns among some ...
Chicago, July 21 (Reuters) - Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely-watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight the novel coronavirus without serious side effects. Whether any of these efforts will result in a vaccine capable of protecting billions of ...
London, July 20 (Reuters) - AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday. The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain’s University of Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial ...
London/Ottawa, July 17 (Reuters) - Hackers backed by the Russian state are trying to steal COVID-19 vaccine and treatment research from academic and pharmaceutical institutions around the world, Britain’s National Cyber Security Centre (NCSC) said on Thursday. A co-ordinated statement from Britain, the United States and Canada attributed the attacks to group APT29, also known as Cozy Bear, which they ...
Chicago, July 7 (Reuters) - The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021. The award is the biggest yet from “Operation Warp Speed”, the White House program aimed at accelerating access to vaccines ...
June 13 (AFP) - China has mobilised its army and fast-tracked tests in the global race to find a coronavirus vaccine, but its labs also have an image tarnished by past health scandals to overcome. Six months after the first cases emerged in the city of Wuhan, China has moved quickly to develop a vaccine and is involved in several ...
